Citation tools
"A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of Oral SCIO-469, a p38 Mitogen-activated Protein Kinase Inhibitor, in Patients with Active Rheumatoid Arthritis." The Journal of Rheumatology
38.5
(2011):
846-854.
Web. 28 Mar. 2024.